Home > Financial Ratios > INDO US BIOTECH

INDO US BIOTECH
Fixed Capital/Sales

    Back to All Ratios
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.080.100.100.080.05

What is the latest Fixed Capital/Sales ratio of INDO US BIOTECH ?

The latest Fixed Capital/Sales ratio of INDO US BIOTECH is 0.08 based on Mar2025 Standalone results.
Year Fixed Capital/Sales
Mar20250.08
Mar20240.10
Mar20230.10
Mar20220.08
Mar20210.05

How is Fixed Capital/Sales of INDO US BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.08
-20.00
Mar2024 0.1
0.00
Mar2023 0.1
25.00
Mar2022 0.08
60.00
Mar2021 0.05 -

Other Financial Ratios of INDO US BIOTECH


Compare Fixed Capital/Sales ratio of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹206.3 Cr 3.4% -22.3% -47.1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,560.0 Cr -3.9% -15.5% -11.5% Stock Analytics
KAVERI SEED COMPANY ₹4,099.2 Cr -0.4% -8.6% -22.2% Stock Analytics
VENKYS (INDIA) ₹1,760.2 Cr -3% -13.1% -24% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹826.5 Cr -5.5% -13.6% -36.6% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹329.9 Cr -1.1% -17.4% -32.6% Stock Analytics


INDO US BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

3.4%

-22.3%

-47.1%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses